Equities research analysts expect Colgate-Palmolive (NYSE:CL) to announce earnings of $0.79 per share for the current quarter, according to Zacks Investment Research. Five analysts have made estimates for Colgate-Palmolive’s earnings. The lowest EPS estimate is $0.72 and the highest is $0.82. Colgate-Palmolive posted earnings of $0.75 per share during the same quarter last year, which would indicate a positive year over year growth rate of 5.3%. The company is scheduled to issue its next quarterly earnings report on Friday, May 7th.
On average, analysts expect that Colgate-Palmolive will report full-year earnings of $3.29 per share for the current fiscal year, with EPS estimates ranging from $3.25 to $3.37. For the next year, analysts forecast that the business will report earnings of $3.51 per share, with EPS estimates ranging from $3.43 to $3.62. Zacks’ EPS calculations are an average based on a survey of sell-side research analysts that follow Colgate-Palmolive.
Colgate-Palmolive (NYSE:CL) last posted its earnings results on Thursday, January 28th. The company reported $0.77 EPS for the quarter, topping the consensus estimate of $0.76 by $0.01. The firm had revenue of $4.32 billion for the quarter, compared to analyst estimates of $4.15 billion. Colgate-Palmolive had a return on equity of 383.88% and a net margin of 16.65%. Colgate-Palmolive’s revenue for the quarter was up 7.7% compared to the same quarter last year. During the same period last year, the company earned $0.73 earnings per share.
CL traded up $0.60 on Tuesday, hitting $77.87. 131,138 shares of the company were exchanged, compared to its average volume of 4,843,766. The company has a market cap of $66.75 billion, a price-to-earnings ratio of 24.88, a price-to-earnings-growth ratio of 3.83 and a beta of 0.59. The company has a current ratio of 0.97, a quick ratio of 0.62 and a debt-to-equity ratio of 6.50. The firm has a 50-day moving average price of $79.87 and a two-hundred day moving average price of $80.52. Colgate-Palmolive has a twelve month low of $58.49 and a twelve month high of $86.41.
The business also recently declared a quarterly dividend, which was paid on Tuesday, February 16th. Investors of record on Monday, January 25th were issued a dividend of $0.44 per share. This represents a $1.76 annualized dividend and a dividend yield of 2.26%. The ex-dividend date of this dividend was Friday, January 22nd. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 62.19%.
In related news, insider Jennifer Daniels sold 20,692 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, February 4th. The shares were sold at an average price of $78.65, for a total transaction of $1,627,425.80. Following the sale, the insider now directly owns 55,585 shares of the company’s stock, valued at approximately $4,371,760.25. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider John W. Kooyman sold 463 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, February 16th. The shares were sold at an average price of $77.16, for a total transaction of $35,725.08. Following the sale, the insider now directly owns 7,160 shares in the company, valued at $552,465.60. The disclosure for this sale can be found here. Insiders have sold a total of 30,810 shares of company stock worth $2,418,650 over the last ninety days. 0.78% of the stock is currently owned by insiders.
Large investors have recently bought and sold shares of the stock. Atlas Brown Inc. acquired a new stake in Colgate-Palmolive during the 4th quarter worth approximately $203,000. Assenagon Asset Management S.A. boosted its position in Colgate-Palmolive by 1,699.9% during the 4th quarter. Assenagon Asset Management S.A. now owns 291,572 shares of the company’s stock worth $24,932,000 after buying an additional 275,373 shares during the period. Flputnam Investment Management Co. boosted its position in Colgate-Palmolive by 20.8% during the 4th quarter. Flputnam Investment Management Co. now owns 12,314 shares of the company’s stock worth $1,053,000 after buying an additional 2,122 shares during the period. Congress Asset Management Co. MA lifted its position in shares of Colgate-Palmolive by 2.4% in the 4th quarter. Congress Asset Management Co. MA now owns 117,174 shares of the company’s stock worth $10,020,000 after purchasing an additional 2,746 shares during the period. Finally, Creative Planning lifted its position in shares of Colgate-Palmolive by 8.4% in the 4th quarter. Creative Planning now owns 91,564 shares of the company’s stock worth $7,830,000 after purchasing an additional 7,134 shares during the period. Institutional investors and hedge funds own 76.47% of the company’s stock.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment products include toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items.
Further Reading: Stock Symbols and CUSIP Explained
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.